---
title: "Mechanical phenotypes of circulating tumor cells predict prostate cancer outcomes"
id: "biorxiv-0-strategies-of-mechanical-adaptations-of-circulating-tumor-cells-and-properties"
canonical_url: "https://medichelpline.com/clinical-feed/biorxiv-0-strategies-of-mechanical-adaptations-of-circulating-tumor-cells-and-properties"
content_type: "clinical_feed_article"
specialty: "Oncology"
source_name: "bioRxiv (Biomedical Preprints)"
source_url: "https://www.biorxiv.org/content/10.64898/2026.10.31.763352v1?rss=1"
published_at: "2026-11-02T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Mechanical phenotypes of circulating tumor cells predict prostate cancer outcomes
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/biorxiv-0-strategies-of-mechanical-adaptations-of-circulating-tumor-cells-and-properties
- **Specialty:** [Oncology](https://medichelpline.com/clinical-feed/oncology.md)
- **Primary Source:** bioRxiv (Biomedical Preprints)
- **Source URL:** [Original Journal Publication](https://www.biorxiv.org/content/10.64898/2026.10.31.763352v1?rss=1)
- **Published At:** 2026-11-02T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The study used atomic force spectroscopy–based force spectrometry to profile mechanical properties of live **circulating tumor cells** (CTCs) isolated from peripheral blood of prostate cancer patients. The assay defined a concept the authors call “mechanical fitness,” a set of physical characteristics linked to CTC survival in circulation. - Investigators observed at least three distinct mechanical adaptation strategies among CTCs: erythrocyte-like high stiffness, leukocyte-like high deformability, and a clustering phenotype marked by exceptionally high **adhesion** that is not seen in normal blood cells. These strategies varied within and between patients. - The cohort-level abundance of highly adhesive CTCs carried predictive information for patients initiating first-line androgen deprivation therapy; the authors reported that elevated adhesion correlated with early castration resistance risk (source text statement). - A patient-specific high adhesion score, calculated from individual-cell or average adhesion values, helped stratify patients with recurrent disease who had undergone diagnostic imaging by **PSMA-PET/CT**, and clarified some inconclusive PSMA scan results according to the authors’ analysis. - Including the erythrocyte-like (high stiffness) subpopulation improved the predictive value of mechanophenotyping. The authors reported that composite metrics combining mechanical phenotype and elements of the **CTC microenvironment** outperformed single-parameter approaches for predicting early castration resistance. - The study team described the **CTC microenvironment** as large cells that co-purify during microfiltration of patient blood. They associated specific microenvironment components with the clustering/adhesive strategy and identified highly adhesive CTCs exhibiting epithelial-to-mesenchymal transition (CTC-EMT). - In more advanced disease, the authors noted that adhesiveness of CTC-EMT was overtaken by **tumor hybrid cells (THCs)**—cells formed by incomplete phagocytosis of CTCs by macrophages. THCs showed altered mechanical phenotypes and shifts in strategy preference as disease progressed, suggesting dynamic adaptation. - The preprint states prior demonstrations of microenvironment composition by this group; it also emphasizes that the paper has not undergone peer review. The source did not provide detailed sample sizes, statistical values, or specific assay parameters in the abstract; those methodological details were not reported in the provided source text.
## Clinical Analysis & Structured Key Points
[Skip to main content](https://www.biorxiv.org/content/10.64898/2026.10.31.763352v1?rss=1#main-content) [![bioRxiv](https://www.biorxiv.org/sites/default/files/biorxiv_article_logo.jpg)](https://www.biorxiv.org/) * [Home](https://www.biorxiv.org/) * [Submit](https://www.biorxiv.org/submit-a-manuscript) * [FAQ](https://www.biorxiv.org/about/FAQ) * [Blog](https://connect.biorxiv.org/news/) * [ALERTS / RSS](https://www.biorxiv.org/content/alertsrss) * [Resources](https://connect.biorxiv.org/resources/) * [About](https://www.biorxiv.org/content/about-biorxiv) * [Channels](https://www.biorxiv.org/content/10.64898/2026.10.31.763352v1?rss=1) * [4D Nucleome](https://connect.biorxiv.org/relate/content/66) * [Academia Sinica](https://connect.biorxiv.org/group/content/38) * [Advances in Genome Biology and Technology (AGBT) General Meeting 2016 #AGBT16](https://connect.biorxiv.org/relate/content/10) * [Albert Einstein College of Medicine](https://connect.biorxiv.org/group/content/4) * [Aligning Science Across Parkinson's (ASAP)](https://connect.biorxiv.org/relate/content/195) * [Allen Institute for Cell Science](https://connect.biorxiv.org/relate/content/71) * [Arc Institute](https://connect.biorxiv.org/relate/content/224) * [Babraham Institute](https://connect.biorxiv.org/relate/content/197) * [BICCN/BICAN](https://connect.biorxiv.org/relate/content/208) * [BioImaging North America](https://connect.biorxiv.org/relate/content/194) * [Biology of Genomes 2016 #BOG16](https://connect.biorxiv.org/relate/content/19) * [Breakthrough Discoveries for Thriving with Bipolar Disorder](https://connect.biorxiv.org/relate/content/236) * [Brown University](https://connect.biorxiv.org/group/content/9) * [California Institute of Technology](https://connect.biorxiv.org/group/content/32) * [Carnegie Mellon University](https://connect.biorxiv.org/group/content/19) * [Case Western Reserve University](https://connect.biorxiv.org/group/content/36) * [Central Oxford Structural Microscopy and Imaging](https://connect.biorxiv.org/relate/content/143) * [Centre for Microbiology and Environmental Systems Science](https://connect.biorxiv.org/relate/content/190) * [Chan Zuckerberg Biohub](https://connect.biorxiv.org/relate/content/121) * [Columbia University](https://connect.biorxiv.org/group/content/27) * [Donders Institute for Brain, Cognition and Behaviour](https://connect.biorxiv.org/relate/content/184) * [DREAM](https://connect.biorxiv.org/relate/content/153) * [Drug Development and Clinical Therapeutics](https://connect.biorxiv.org/relate/content/52) * [ENCODE](https://connect.biorxiv.org/relate/content/177) * [Ernst Strüngmann Institute (ESI) for Neuroscience](https://connect.biorxiv.org/relate/content/211) * [European Molecular Biology Laboratory (EMBL)](https://connect.biorxiv.org/relate/content/159) * [Francis Crick Institute](https://connect.biorxiv.org/relate/content/88) * [Fred Hutchinson Cancer Center](https://connect.biorxiv.org/group/content/28) * [Georgia Institute of Technology](https://connect.biorxiv.org/group/content/20) * [Harvard Program in Therapeutic Sciences](https://connect.biorxiv.org/relate/content/151) * [The Howard Hughes Medical Institute (HHMI)](https://connect.biorxiv.org/relate/content/227) * [Human Cell Atlas](https://connect.biorxiv.org/relate/content/163) * [Human Pangenome Reference Consortium (HPRC)](https://connect.biorxiv.org/relate/content/215) * [IMO Workshop](https://connect.biorxiv.org/relate/content/8) * [Impact of Genomic Variation on Function (IGVF)](https://connect.biorxiv.org/relate/content/214) * [Institut Pasteur](https://connect.biorxiv.org/relate/content/235/channel) * [Institute of Science and Technology Austria](https://connect.biorxiv.org/group/content/12) * [International Human Epigenome Consortium (IHEC)](https://connect.biorxiv.org/relate/content/219) * [International Mouse Phenotyping Consortium (IMPC)](https://connect.biorxiv.org/relate/content/185) * [Iowa State University](https://connect.biorxiv.org/group/content/6) * [Johns Hopkins University](https://connect.biorxiv.org/group/content/47) * [Mathematical Oncology](https://connect.biorxiv.org/relate/content/1) * [Micron Oxford](https://connect.biorxiv.org/relate/content/116) * [Michigan State University](https://connect.biorxiv.org/group/content/7) * [Morgridge Institute](https://connect.biorxiv.org/group/content/57) * [National Taiwan University](https://connect.biorxiv.org/group/content/39) * [NCI Cancer Systems Biology Consortium](https://connect.biorxiv.org/relate/content/210) * [NF Open Science Initiative](https://connect.biorxiv.org/relate/content/213) * [NCI Human Tumor Atlas Network](https://connect.biorxiv.org/relate/content/171) * [Neuromatch Conference](https://connect.biorxiv.org/relate/content/209) * [NeurotechEU](https://connect.biorxiv.org/relate/content/189) * [North Carolina State University](https://connect.biorxiv.org/group/content/37) * [Northeastern University](https://connect.biorxiv.org/group/content/54) * [Oregon Health & Sciences University](https://connect.biorxiv.org/group/content/22) * [RNA Therapeutics Institute at UMass Chan Med School](https://connect.biorxiv.org/relate/content/243) * [Rosetta Commons](https://connect.biorxiv.org/relate/content/191) * [Rutgers University](https://connect.biorxiv.org/group/content/31) * [SeroNet](https://connect.biorxiv.org/relate/content/192) * [Simons Foundation Autism Research Initiative (SFARI)](https://connect.biorxiv.org/relate/content/74) * [Society for Molecular Biology and Evolution #SMBE2016](https://connect.biorxiv.org/relate/content/29) * [Somatic Cell Genome Editing Program](https://connect.biorxiv.org/relate/content/167) * [Somatic Mosaicism across the Human Tissues Network](https://connect.biorxiv.org/relate/content/222) * [SPARC](https://connect.biorxiv.org/relate/content/187) * [Stowers Institute for Medical Research](https://connect.biorxiv.org/group/content/3) * [Stockholm University](https://connect.biorxiv.org/group/content/14) * [Tel Aviv University](https://connect.biorxiv.org/group/content/8) * [The Michael J. Fox Foundation](https://connect.biorxiv.org/relate/content/207) * [The Rockefeller University](https://connect.biorxiv.org/group/content/2) * [The Sainsbury Laboratory](https://connect.biorxiv.org/relate/content/98) * [The Whitehead Institute](https://connect.biorxiv.org/relate/content/212) * [University of Connecticut Health Center](https://connect.biorxiv.org/group/content/16) * [University of California, Berkeley](https://connect.biorxiv.org/group/content/13) * [University of California, San Diego](https://connect.biorxiv.org/group/content/41) * [University of California, San Francisco](https://connect.biorxiv.org/group/content/10) * [University of Chicago](https://connect.biorxiv.org/group/content/42) * [University of Geneva](https://connect.biorxiv.org/group/content/26) * [University of Guelph](https://connect.biorxiv.org/group/content/23) * [University of Hong Kong](https://connect.biorxiv.org/group/content/29) * [University of Illinois Chicago](https://connect.biorxiv.org/group/content/43) * [University of Iowa](https://connect.biorxiv.org/group/content/24) * [University of Kansas](https://connect.biorxiv.org/group/content/33) * [University of Massachusetts Chan Medical School](https://connect.biorxiv.org/group/content/44) * [University of New South Wales](https://connect.biorxiv.org/group/content/25) * [University of Ottawa](https://connect.biorxiv.org/group/content/35) * [University of Sydney](https://connect.biorxiv.org/group/content/50) * [Vanderbilt University](https://connect.biorxiv.org/group/content/30) * [Vienna BioCenter](https://connect.biorxiv.org/relate/content/186) * [Washington University in St. Louis](https://connect.biorxiv.org/group/content/11) * [Weizmann Institute of Science](https://connect.biorxiv.org/group/content/15) * [Yale University](https://connect.biorxiv.org/group/content/53) Search for this keyword [Advanced Search](https://www.biorxiv.org/search) New Results Follow this preprint # Strategies of mechanical adaptations of circulating tumor cells and properties of their cellular microenvironment have predictive and prognostic biomarker value [ View ORCID Profile](http://orcid.org/0000-0002-9033-5706)Maria Gaczynska, Fatemeh Ataei, Chih-Wei Chou, Matthew A Click, Furkan Dursun, [ View ORCID Profile](http://orcid.org/0000-0002-4976-4883)Chia-Nung Hung, Kerri A Kendrick, Robin Leach, Michael A Liss, Penny Vroman, Zhao Zhang, Tim Hui-Ming Huang, [ View ORCID Profile](http://orcid.org/0000-0002-5359-9200)Pawel A Osmulski doi: https://doi.org/10.64898/2026.10.31.763352 This article is a preprint and has not been certified by peer review [[what does this mean?](https://www.biorxiv.org/about/FAQ#unrefereed)]. Maria Gaczynska 1 The University of Texas Health Science Center at San Antonio; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Maria%2BGaczynska%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Gaczynska%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AMaria%2BGaczynska%2B) * [ORCID record for Maria Gaczynska](http://orcid.org/0000-0002-9033-5706 "Open in new tab") * For correspondence: gaczynska@uthscsa.edu Fatemeh Ataei 1 The University of Texas Health Science Center at San Antonio; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Fatemeh%2BAtaei%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Ataei%20F&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AFatemeh%2BAtaei%2B) Chih-Wei Chou 1 The University of Texas Health Science Center at San Antonio; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Chih-Wei%2BChou%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Chou%20C&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AChih-Wei%2BChou%2B) Matthew A Click 1 The University of Texas Health Science Center at San Antonio; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Matthew%2BA%2BClick%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Click%20MA&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AMatthew%2BA%2BClick%2B) Furkan Dursun 1 The University of Texas Health Science Center at San Antonio; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Furkan%2BDursun%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Dursun%20F&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AFurkan%2BDursun%2B) Chia-Nung Hung 1 The University of Texas Health Science Center at San Antonio; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Chia-Nung%2BHung%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Hung%20C&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AChia-Nung%2BHung%2B) * [ORCID record for Chia-Nung Hung](http://orcid.org/0000-0002-4976-4883 "Open in new tab") Kerri A Kendrick 1 The University of Texas Health Science Center at San Antonio; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Kerri%2BA%2BKendrick%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Kendrick%20KA&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AKerri%2BA%2BKendrick%2B) Robin Leach 2 UT Health Science Center; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Robin%2BLeach%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Leach%20R&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ARobin%2BLeach%2B) Michael A Liss 3 University of California, San Diego * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Michael%2BA%2BLiss%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Liss%20MA&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AMichael%2BA%2BLiss%2B) Penny Vroman 1 The University of Texas Health Science Center at San Antonio; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Penny%2BVroman%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Vroman%20P&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3APenny%2BVroman%2B) Zhao Zhang 1 The University of Texas Health Science Center at San Antonio; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Zhao%2BZhang%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Zhang%20Z&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AZhao%2BZhang%2B) Tim Hui-Ming Huang 1 The University of Texas Health Science Center at San Antonio; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Tim%2BHui-Ming%2BHuang%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Huang%20TH&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ATim%2BHui-Ming%2BHuang%2B) Pawel A Osmulski 1 The University of Texas Health Science Center at San Antonio; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Pawel%2BA%2BOsmulski%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Osmulski%20PA&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3APawel%2BA%2BOsmulski%2B) * [ORCID record for Pawel A Osmulski](http://orcid.org/0000-0002-5359-9200 "Open in new tab") * [Abstract](https://www.biorxiv.org/content/10.64898/2026.10.31.763352v1)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_art/node:5926671/1) * [Info/History](https://www.biorxiv.org/content/10.64898/2026.10.31.763352v1.article-info)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_info/node:5926671/1) * [Metrics](https://www.biorxiv.org/content/10.64898/2026.10.31.763352v1.article-metrics)[](https://www.biorxiv.org/panels_ajax_tab/article_tab_metrics/node:5926671/1) * [ Preview PDF](https://www.biorxiv.org/content/10.64898/2026.10.31.763352v1.full.pdf+html)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:5926671/1) ![Loading](https://www.biorxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Mechanically demanding conditions in the blood circulation damage and kill majority of tumor-shed circulating tumor cells (CTCs). Mechanical fitness: a set of mechanical properties detected with atomic force spectroscopy based force spectrometry supports survival of CTCs. We propose that live CTCs isolated from peripheral blood of prostate cancer patients represent distinct strategies of fitness promoting mechanical adaptations to the fluid shear stress. Some of the cells mimicked properties of erythrocytes (high stiffness) or leukocytes (high deformability). The clustering strategy characterized by exceptionally high adhesion is ingenious to CTCs and not found in blood cells. The abundance of CTCs with elevated adhesion has a predictive value for prostate cancer patients starting first round of androgen deprivation therapy. Moreover, a high adhesion score based on individual cells or average patient-specific adhesion is instrumental to stratify recurrent patients that underwent diagnostic imaging by PSMA-PET/CT and clarify inconclusive PSMA scan results. Including contribution of erythrocyte-like strategy broadened the predictive power of CTC mechanophenotyping. Improved biomarking opportunities to predict early castration resistances were noted when the composition of CTC microenvironment was included alongside the mechanical properties. We demonstrated previously that the CTC microenvironment is formed by large cells co-purifying by microfiltration of the blood of cancer patients. Analysis of the association of particular components of CTC microenvironment with the clustering strategy led to pointing at highly adhesive CTC-EMT. However, in the advanced patients adhesiveness of CTC-EMT was surpassed by tumor hybrid cells (THCs), a distinctive kind of invasive species formed by incomplete phagocytosis of CTCs by macrophages. THCs changed their mechanical phenotype and strategy preference with disease progression pointing at the dynamic nature of adaptations of tumor-shed cells to circulation conditions. ### Competing Interest Statement The authors have declared no competing interest. ## Funder Information Declared Nationa Institutes of Health, U01CA283749, R61CA291213, S10OD034419-01 DoD, PC170821 Copyright The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.biorxiv.org/content/10.64898/2026.10.31.763352v1?rss=1#page) [ Previous](https://www.biorxiv.org/content/10.64898/2026.07.06.736881v2 "Kinetics and Evolution-guided Design o
## Related Clinical Research

- [Minor intron splicing limits E2F activity in RB-deregulated prostate cancer (preprint)](https://medichelpline.com/clinical-feed/biorxiv-0-minor-intron-splicing-restricts-e2f-transcription-factor-activity-in-rb.md)
- [Fluid-walled microfluidics isolates migratory cancer cell subpopulations in standard Petri dishes](https://medichelpline.com/clinical-feed/biorxiv-13-identification-and-isolation-of-migratory-subpopulations-of-cancer-cells-using.md)
- [Replacing animal fats with plant fats linked to lower mortality after nonmetastatic prostate cancer](https://medichelpline.com/clinical-feed/medical-news-today-0-swapping-animal-fats-with-plant-fats-may-lower-risk-of-death-after-prostate.md)
- [Induced proximity therapies: PROTACs, molecular glues and RIPTACs in oncology](https://medichelpline.com/clinical-feed/nature-3-induced-proximity-comes-of-age.md)
- [High-resolution map of the basal ganglia reveals cell types tied to Parkinson’s and schizophrenia](https://medichelpline.com/clinical-feed/stat-news-1-stat-scientists-debut-map-of-basal-ganglia-a-key-brain-region-involved-in-an.md)

## Navigation
- [← Back to Oncology Feed](https://medichelpline.com/clinical-feed/oncology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.